Anti-tumor action of trichosanthin, a type 1 ribosome-inactivating protein, employed in traditional Chinese medicine: a mini review
Ou ShaSchool of Medicine, Shenzhen University, Shenzhen, China. [email protected]Junfei NiuSchool of Medicine, Shenzhen University, Shenzhen, ChinaTzi‐Bun NgFaculty of Medicine, School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, ChinaEric ChoFaculty of Medicine, School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, ChinaXiaoyuan FuSchool of Medicine, Shenzhen University, Shenzhen, ChinaWenqi JiangSchool of Medicine, Shenzhen University, Shenzhen, China
2013en
ABI
Аннотация
Trichosanthin (TCS) as a midterm abortifacient medicine has been used clinically in traditional Chinese medicine for centuries. Additionally, TCS manifests a host of pharmacological properties, for instance, anti-HIV and anti-tumor activities. TCS has been reported to inhibit cell growth of a diversity of cancers, including cervical cancer, choriocarcinoma, and leukemia/lymphoma, etc. This article purported to review the various anti-tumor activities of TCS and the mechanism of apoptosis it induced in these tumor cells. These research progresses provide an insight into cancer research and treatment as well as disclose new pharmacological properties of the ancient but popular Chinese medicine.
Перевод пока недоступен
Идентификаторы
Цитирования и источники
Цитирований: 2Использованных источников: 0